nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative trial of risedronate vs. etidronate in the treatment of patients with Paget’s disease of bone
|
Miller, P.D |
|
1999 |
|
5S1 |
p. 93S- 1 p. |
artikel |
2 |
Adult bone and mineral working group
|
|
|
1998 |
|
5S1 |
p. S74- 1 p. |
artikel |
3 |
Advanced imaging surrogates of bone strength
|
Müller, Ralph |
|
2007 |
|
5S1 |
p. S33- 1 p. |
artikel |
4 |
Afternoon concurrent oral sessions
|
|
|
1998 |
|
5S1 |
p. S109-S110 2 p. |
artikel |
5 |
Afternoon concurrent oral sessions
|
|
|
1998 |
|
5S1 |
p. S116-S142 27 p. |
artikel |
6 |
A marker for type I collagen degradation identified in urine from patients with Paget’s disease of bone
|
Krane, S.M |
|
1999 |
|
5S1 |
p. 52S- 1 p. |
artikel |
7 |
A multicenter study of chromosome 18q linkage in familial Paget’s disease
|
Hocking, L.J |
|
1999 |
|
5S1 |
p. 31S- 1 p. |
artikel |
8 |
Analgesic effect of calcitonin in osteoporosis
|
Gennari, C |
|
2002 |
|
5S1 |
p. 67-70 4 p. |
artikel |
9 |
Analgesic effects of calcitonin
|
Lyritis, G.P |
|
2002 |
|
5S1 |
p. 71-74 4 p. |
artikel |
10 |
A new radioimmunoassay for C-terminal telopeptide of type I collagen in the diagnosis and follow-up of Paget’s disease
|
Gonnelli, S |
|
1999 |
|
5S1 |
p. 52S- 1 p. |
artikel |
11 |
Animal-related risk factors in Spanish patients with Paget’s disease of bone
|
Morales-Piga, A |
|
1999 |
|
5S1 |
p. 15S- 1 p. |
artikel |
12 |
Announcements
|
|
|
1995 |
|
5S1 |
p. S521- 1 p. |
artikel |
13 |
Antifracture efficacy of strontium ranelate in postmenopausal osteoporosis
|
Roux, Christian |
|
2007 |
|
5S1 |
p. S9-S11 3 p. |
artikel |
14 |
A Nude Mouse Model for Human Bone Formation in Unloaded Conditions
|
Muraglia, A |
|
1998 |
|
5S1 |
p. 131S-134S nvt p. |
artikel |
15 |
A randomized treatment trial of intravenous pamidronate and oral alendronate in Paget’s disease: early results
|
Gutteridge, D.H |
|
1999 |
|
5S1 |
p. 67S-68S nvt p. |
artikel |
16 |
Are paramyxoviruses involved in paget’s disease? A negative view
|
Ralston, S.H |
|
1999 |
|
5S1 |
p. 17S-18S nvt p. |
artikel |
17 |
ASBMR awards dinner
|
|
|
1998 |
|
5S1 |
p. S39- 1 p. |
artikel |
18 |
ASBMR business meeting
|
|
|
1998 |
|
5S1 |
p. S73- 1 p. |
artikel |
19 |
ASBMR-IBMS banquet & awards ceremony
|
|
|
1998 |
|
5S1 |
p. S143-S144 2 p. |
artikel |
20 |
ASBMR-IBMS dance & cash bar
|
|
|
1998 |
|
5S1 |
p. S145- 1 p. |
artikel |
21 |
ASMBR-IBMS reception at the San Francisco museum of modern art
|
|
|
1998 |
|
5S1 |
p. S79- 1 p. |
artikel |
22 |
Author index
|
|
|
1998 |
|
5S1 |
p. S681-S708 28 p. |
artikel |
23 |
Author index
|
|
|
2001 |
|
5S1 |
p. S275-S286 12 p. |
artikel |
24 |
Biochemical markers of bone turnover in Paget’s disease of bone
|
Eastell, R |
|
1999 |
|
5S1 |
p. 49S-50S nvt p. |
artikel |
25 |
Biochemical markers of bone turnover in predicting response to clodronate therapy in Paget’s disease
|
Parker, C.R. |
|
1999 |
|
5S1 |
p. 68S- 1 p. |
artikel |
26 |
Bisphosphonate action on bone structure and strength: Preclinical and clinical evidence for ibandronate
|
Müller, Ralph |
|
2007 |
|
5S1 |
p. S16-S23 8 p. |
artikel |
27 |
Bisphosphonate antifracture efficacy
|
Adami, Silvano |
|
2007 |
|
5S1 |
p. S8-S15 8 p. |
artikel |
28 |
Bisphosphonates: The evolution of a gold standard
|
Russell, Graham |
|
2007 |
|
5S1 |
p. S29- 1 p. |
artikel |
29 |
Bone remodelling and antifracture efficacy of oral bisphosphonate therapy
|
Papapoulos, Socrates E. |
|
2007 |
|
5S1 |
p. S32- 1 p. |
artikel |
30 |
Calcaneus as a Site for the Assessment of Bone Mass
|
Sone, T |
|
1998 |
|
5S1 |
p. 155S-157S nvt p. |
artikel |
31 |
Calcitonin, an update
|
Martin, T.J |
|
1999 |
|
5S1 |
p. 63S-65S nvt p. |
artikel |
32 |
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis
|
Body, J.-J |
|
2002 |
|
5S1 |
p. 75-79 5 p. |
artikel |
33 |
Calcitonin in osteoporosis
|
Kanis, J.A. |
|
2002 |
|
5S1 |
p. 65-66 2 p. |
artikel |
34 |
Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions
|
Appelboom, T |
|
2002 |
|
5S1 |
p. 84-86 3 p. |
artikel |
35 |
Cellular and molecular regulation of bone turnover
|
Mundy, G.R |
|
1999 |
|
5S1 |
p. 35S-38S nvt p. |
artikel |
36 |
Concurrent oral session 27 Bone, cartilage and connective tissue matrix II
|
|
|
1998 |
|
5S1 |
p. S147- 1 p. |
artikel |
37 |
Concurrent oral session 1 Bone cells: Osteoblasts I
|
|
|
1998 |
|
5S1 |
p. S5- 1 p. |
artikel |
38 |
Concurrent oral session 3 Bone cells: Osteoblasts II
|
|
|
1998 |
|
5S1 |
p. S35-S36 2 p. |
artikel |
39 |
Concurrent oral session 9 Bone cells: Osteoclasts I
|
|
|
1998 |
|
5S1 |
p. S71-S72 2 p. |
artikel |
40 |
Concurrent oral session 2 Osteoporosis: Epidemiology I
|
|
|
1998 |
|
5S1 |
p. S6- 1 p. |
artikel |
41 |
Concurrent oral session 12 Osteoporosis: Epidemiology II
|
|
|
1998 |
|
5S1 |
p. S73- 1 p. |
artikel |
42 |
Concurrent oral session 7 Osteoporosis: Genetics
|
|
|
1998 |
|
5S1 |
p. S41- 1 p. |
artikel |
43 |
Concurrent oral session 8 Peptide calciotropic hormones II
|
|
|
1998 |
|
5S1 |
p. S42-S71 30 p. |
artikel |
44 |
Concurrent plenary lectures
|
|
|
1998 |
|
5S1 |
p. S114- 1 p. |
artikel |
45 |
Concurrent plenary lectures
|
|
|
1998 |
|
5S1 |
p. S81- 1 p. |
artikel |
46 |
Concurrent plenary lectures
|
|
|
1998 |
|
5S1 |
p. S41- 1 p. |
artikel |
47 |
Concurrent plenary lectures
|
|
|
1998 |
|
5S1 |
p. S78- 1 p. |
artikel |
48 |
Considerations in building the evidence in osteoporosis management
|
Reginster, Jean-Yves |
|
2007 |
|
5S1 |
p. S30-S31 2 p. |
artikel |
49 |
Contact information
|
|
|
2001 |
|
5S1 |
p. v- 1 p. |
artikel |
50 |
Continuous combined HRT and bisphosphonates in osteoporosis: Similarities and differences
|
Kanis, J.A. |
|
1996 |
|
5S1 |
p. 177S- 1 p. |
artikel |
51 |
Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis
|
McClung, M.R. |
|
1996 |
|
5S1 |
p. 195S-198S nvt p. |
artikel |
52 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S1- 1 p. |
artikel |
53 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S113- 1 p. |
artikel |
54 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S145- 1 p. |
artikel |
55 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S4- 1 p. |
artikel |
56 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S40- 1 p. |
artikel |
57 |
Day-at-a-glance
|
|
|
1998 |
|
5S1 |
p. S77- 1 p. |
artikel |
58 |
Day-at-glance
|
|
|
1998 |
|
5S1 |
p. S80- 1 p. |
artikel |
59 |
Demonstration of canine distemper virus in pagetic bone: possible explanation for failure to detect viruses using reverse transcriptase-polymerase chain reaction
|
Dixon, J.A |
|
1999 |
|
5S1 |
p. 27S- 1 p. |
artikel |
60 |
Determinants of bone strength and clinical practice; effects of bisphosphonates
|
Papapoulos, Socrates E. |
|
2007 |
|
5S1 |
p. S3-S7 5 p. |
artikel |
61 |
Direct identification of osteoblast progenitor cells in Paget’s disease
|
Joyner, C.J |
|
1999 |
|
5S1 |
p. 41S- 1 p. |
artikel |
62 |
Editorial
|
|
|
1998 |
|
5S1 |
p. 101S-102S nvt p. |
artikel |
63 |
Editorial
|
|
|
1998 |
|
5S1 |
p. 117S-118S nvt p. |
artikel |
64 |
Editorial
|
|
|
1998 |
|
5S1 |
p. 71S- 1 p. |
artikel |
65 |
Editorial
|
|
|
1998 |
|
5S1 |
p. 159S-161S nvt p. |
artikel |
66 |
Editorial
|
|
|
1998 |
|
5S1 |
p. 135S-137S nvt p. |
artikel |
67 |
Editorial
|
|
|
1999 |
|
5S1 |
p. I-II nvt p. |
artikel |
68 |
Editorial
|
|
|
1999 |
|
5S1 |
p. III- 1 p. |
artikel |
69 |
Editorial Board
|
|
|
1998 |
|
5S1 |
p. i- 1 p. |
artikel |
70 |
Editorial Board
|
|
|
2007 |
|
5S1 |
p. i-ii nvt p. |
artikel |
71 |
Editorial Board
|
|
|
2007 |
|
5S1 |
p. i-ii nvt p. |
artikel |
72 |
Effect of Mechanical Unloading and Reloading on Periosteal Bone Formation and Gene Expression in Tail-Suspended Rapidly Growing Rats
|
Matsumoto, T |
|
1998 |
|
5S1 |
p. 89S-93S nvt p. |
artikel |
73 |
Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women
|
Eiken, P. |
|
1996 |
|
5S1 |
p. 191S-193S nvt p. |
artikel |
74 |
Effects of Gravitational Changes on the Bone System In Vitro and In Vivo
|
Vico, L |
|
1998 |
|
5S1 |
p. 95S-100S nvt p. |
artikel |
75 |
Efficacy and safety of drugs for Paget's disease of bone
|
Reginster, J.-Y.L. |
|
1995 |
|
5S1 |
p. S485-S488 4 p. |
artikel |
76 |
Epidemiological, clinical, biochemical, and imaging characteristics of monostotic and polyostotic Paget’s disease
|
Monfort, J |
|
1999 |
|
5S1 |
p. 13S-14S nvt p. |
artikel |
77 |
Epidemiology of Paget’s disease of bone
|
Cooper, C |
|
1999 |
|
5S1 |
p. 3S-5S nvt p. |
artikel |
78 |
Estrogens, the menopause, and osteoporosis
|
Kanis, J.A. |
|
1996 |
|
5S1 |
p. 185S-190S nvt p. |
artikel |
79 |
European and North American experience with HRT for the prevention of osteoporosis
|
Eriksen, E.F. |
|
1996 |
|
5S1 |
p. 179S-183S nvt p. |
artikel |
80 |
Evening at the opera/theater/symphony
|
|
|
1998 |
|
5S1 |
p. S79- 1 p. |
artikel |
81 |
Faculty committees
|
|
|
2001 |
|
5S1 |
p. vi-viii nvt p. |
artikel |
82 |
Failure to detect paramyxovirus RNA in bone and osteoblast-like and osteoclast-like cells cultured from patients with Paget’s disease
|
Ooi, C.G |
|
1999 |
|
5S1 |
p. 27S- 1 p. |
artikel |
83 |
Family history and heritability of Paget’s disease: a multicenter study
|
Slee, F. |
|
1999 |
|
5S1 |
p. 32S- 1 p. |
artikel |
84 |
Floorplan
|
|
|
2001 |
|
5S1 |
p. A5-A7 nvt p. |
artikel |
85 |
Foreword
|
Papapoulos, Socrates E. |
|
2007 |
|
5S1 |
p. S2- 1 p. |
artikel |
86 |
Free afternoon
|
|
|
1998 |
|
5S1 |
p. S79- 1 p. |
artikel |
87 |
Future Human Bone Research in Space
|
LeBlanc, A |
|
1998 |
|
5S1 |
p. 113S-116S nvt p. |
artikel |
88 |
Gene Expression Related to the Differentiation of Osteoblastic Cells Is Altered by Microgravity
|
Carmeliet, G |
|
1998 |
|
5S1 |
p. 139S-143S nvt p. |
artikel |
89 |
General information
|
|
|
2001 |
|
5S1 |
p. xi-xii nvt p. |
artikel |
90 |
Genetic epidemiology of Paget’s disease of bone in Eastern Québec
|
Brown, J.P |
|
1999 |
|
5S1 |
p. 15S- 1 p. |
artikel |
91 |
Genetic linkage of Paget’s disease to chromosome 18q in a French pedigree
|
Lucotte, G. |
|
1999 |
|
5S1 |
p. 31S- 1 p. |
artikel |
92 |
Hindlimb Unloading of Growing Rats: A Model for Predicting Skeletal Changes During Space Flight
|
Morey-Holton, E.R |
|
1998 |
|
5S1 |
p. 83S-88S nvt p. |
artikel |
93 |
Human osteoblasts support human monocyte-osteoclast differentiation: evidence of prostaglandin stimulation
|
Neale, S.D |
|
1999 |
|
5S1 |
p. 41S- 1 p. |
artikel |
94 |
Human pharmacokinetics of tiludronate
|
Sansom, L.N. |
|
1995 |
|
5S1 |
p. S479-S483 5 p. |
artikel |
95 |
Ibandronate: An IV injection for the treatment for postmenopausal osteoporosis
|
Rizzoli, René |
|
2007 |
|
5S1 |
p. S24-S28 5 p. |
artikel |
96 |
Ibandronate treatment in Paget’s disease of bone
|
Grauer, A |
|
1999 |
|
5S1 |
p. 87S-89S nvt p. |
artikel |
97 |
IBMS business meeting
|
|
|
1998 |
|
5S1 |
p. S111- 1 p. |
artikel |
98 |
IBMS-ECTS 2001
|
|
|
2001 |
|
5S1 |
p. i- 1 p. |
artikel |
99 |
Immuno terminal domain of Smad1 interacting with Hoxc-8 is sufficient to induce bone cell differentiation
|
Yang, X. |
|
1998 |
|
5S1 |
p. S147-S148 2 p. |
artikel |
100 |
Impaired intramembranous bone formation in connexin43 null mice
|
Lecanda, Fernando |
|
1998 |
|
5S1 |
p. S149-S653 505 p. |
artikel |
101 |
Infrequent neurological manifestations in Paget’s disease of bone
|
Porrini, A.A |
|
1999 |
|
5S1 |
p. 16S- 1 p. |
artikel |
102 |
Intravenous administration: International perspectives
|
Hadji, Peyman |
|
2007 |
|
5S1 |
p. S44- 1 p. |
artikel |
103 |
Intravenous bisphosphonate safety: The realities
|
Miller, Paul D. |
|
2007 |
|
5S1 |
p. S42-S43 2 p. |
artikel |
104 |
Introduction
|
Bouillon, Roger |
|
2007 |
|
5S1 |
p. S1- 1 p. |
artikel |
105 |
In vivo working group
|
|
|
1998 |
|
5S1 |
p. S76- 1 p. |
artikel |
106 |
Isolation of novel genes in Paget’s disease by subtractive hybridization
|
Dixon, J.A |
|
1999 |
|
5S1 |
p. 32S- 1 p. |
artikel |
107 |
Israeli Arabs do have Paget’s disease of bone
|
Dolev, E |
|
1999 |
|
5S1 |
p. 15S- 1 p. |
artikel |
108 |
Key word index
|
|
|
1998 |
|
5S1 |
p. S655-S680 26 p. |
artikel |
109 |
Lessons from the Space Experiment SL-J/FMPT/L7: The Effect of Microgravity on Chicken Embryogenesis and Bone Formation
|
Suda, T |
|
1998 |
|
5S1 |
p. 73S-78S nvt p. |
artikel |
110 |
Lipoprotein(a) serum levels in patients with Paget’s disease and primary hyperparathyroidism
|
Adami, S |
|
1999 |
|
5S1 |
p. 32S-33S nvt p. |
artikel |
111 |
Long-lasting suppression of Paget’s disease activity with cyclical tiludronate treatment
|
Ringe, J.D |
|
1999 |
|
5S1 |
p. 68S- 1 p. |
artikel |
112 |
Long-term follow-up of Paget’s disease: progression despite medical treatment
|
Phillips, A.J |
|
1999 |
|
5S1 |
p. 51S- 1 p. |
artikel |
113 |
Maintaining the life-long vitality and integrity of skeletal tissue
|
Raisz, Lawrence G. |
|
2007 |
|
5S1 |
p. S1-S4 4 p. |
artikel |
114 |
Managing the osteoporotic patient today
|
Reginster, Jean-Yves |
|
2007 |
|
5S1 |
p. S12-S18 7 p. |
artikel |
115 |
Mechanisms of abnormal bone turnover in Paget’s disease
|
Roodman, G.David |
|
1999 |
|
5S1 |
p. 39S-40S nvt p. |
artikel |
116 |
Medical Baseline Data Collection on Bone and Muscle Change with Space Flight
|
Miyamoto, A |
|
1998 |
|
5S1 |
p. 79S-82S nvt p. |
artikel |
117 |
Meet-the-NIH-and-other-funding-sources
|
|
|
1998 |
|
5S1 |
p. S82- 1 p. |
artikel |
118 |
Microgravity and Bone Cell Mechanosensitivity
|
Burger, E.H |
|
1998 |
|
5S1 |
p. 127S-130S nvt p. |
artikel |
119 |
Molecular biology and the pathology of bone working group
|
|
|
1998 |
|
5S1 |
p. S112- 1 p. |
artikel |
120 |
Molecular mechanisms of action of bisphosphonates
|
Rogers, M.J |
|
1999 |
|
5S1 |
p. 73S-79S nvt p. |
artikel |
121 |
Monthly ibandronate: Offering an adherence advantage
|
Stone, Mike |
|
2007 |
|
5S1 |
p. S38-S39 2 p. |
artikel |
122 |
Morning concurrent oral sessions
|
|
|
1998 |
|
5S1 |
p. S115- 1 p. |
artikel |
123 |
Morning concurrent oral sessions
|
|
|
1998 |
|
5S1 |
p. S81- 1 p. |
artikel |
124 |
Morning current oral sessions
|
|
|
1998 |
|
5S1 |
p. S78- 1 p. |
artikel |
125 |
Noninvasive Assessment of Bone Density and Structure Using Computed Tomography and Magnetic Resonance 1 1 This manuscript was partially adapted from Genant, H., Engelke, K., Fuerst, T. Gluer, C. C., Grampp, S., Harris, S. T., Jergas, M., Lang, T., Lu, Y., and Majumdar S. Non-invasive assessment of bone mineral and structure: State of the art. J Bone Miner Res 11:707–729; 1996.
|
Lang, T |
|
1998 |
|
5S1 |
p. 149S-153S nvt p. |
artikel |
126 |
Non-invasive assessment of trabecular bone microarchitecture working group
|
|
|
1998 |
|
5S1 |
p. S2- 1 p. |
artikel |
127 |
Nutrition and bone health working group
|
|
|
1998 |
|
5S1 |
p. S113- 1 p. |
artikel |
128 |
Official social program
|
|
|
2001 |
|
5S1 |
p. xiii- 1 p. |
artikel |
129 |
On Mechanosensation in Bone Under Microgravity
|
Cowin, S.C |
|
1998 |
|
5S1 |
p. 119S-125S nvt p. |
artikel |
130 |
Opening address and announcements
|
|
|
1998 |
|
5S1 |
p. S5- 1 p. |
artikel |
131 |
Oral presentations
|
|
|
2001 |
|
5S1 |
p. S70-S89 20 p. |
artikel |
132 |
Origin of a therapy: The evolution of intravenous bisphosphonates
|
Recker, Robert R. |
|
2007 |
|
5S1 |
p. S40- 1 p. |
artikel |
133 |
Osteoporosis: Diagnosis and management today and tomorrow
|
Christiansen, C. |
|
1995 |
|
5S1 |
p. S513-S516 4 p. |
artikel |
134 |
Paget’s disease from a genetic perspective
|
van Hul, W |
|
1999 |
|
5S1 |
p. 29S-30S nvt p. |
artikel |
135 |
Paget’s disease in New Zealand: Is it changing?
|
Cundy, T |
|
1999 |
|
5S1 |
p. 7S-9S nvt p. |
artikel |
136 |
Paget’s disease of bone: a review of 889 patients
|
Davie, M |
|
1999 |
|
5S1 |
p. 11S-12S nvt p. |
artikel |
137 |
Paget’s disease of bone: past and present
|
Smith, R |
|
1999 |
|
5S1 |
p. 1S-2S nvt p. |
artikel |
138 |
Paget’s disease of bone: remission and relapse after treatment
|
Grauer, A |
|
1999 |
|
5S1 |
p. 67S- 1 p. |
artikel |
139 |
Paget’s disease of bone: rheumatologic complications
|
Altman, R.D |
|
1999 |
|
5S1 |
p. 47S-48S nvt p. |
artikel |
140 |
Paget’s disease of bone: treatment philosophy for the twenty-first century
|
Siris, E.S |
|
1999 |
|
5S1 |
p. 55S-56S nvt p. |
artikel |
141 |
Paget’s disease with primary hyperparathyroidism: gender distribution in 30 cases, and prediction of skeletal response to parathyroidectomy in 18
|
Gutteridge, D.H |
|
1999 |
|
5S1 |
p. 51S- 1 p. |
artikel |
142 |
Pamidronate in acquired immune deficiency syndrome
|
Postlethwaite, A.E |
|
1999 |
|
5S1 |
p. 32S- 1 p. |
artikel |
143 |
Pamidronate in the treatment of Paget’s disease
|
Selby, P.L |
|
1999 |
|
5S1 |
p. 57S-58S nvt p. |
artikel |
144 |
Pamidronate: study of two high-dose regimens in resistant Paget’s disease of bone
|
Buckler, H.M |
|
1999 |
|
5S1 |
p. 67S- 1 p. |
artikel |
145 |
Paramyxoviruses and chronic human diseases
|
Rima, B.K |
|
1999 |
|
5S1 |
p. 23S-26S nvt p. |
artikel |
146 |
Paramyxoviruses and Paget’s disease: the affirmative view
|
Mee, A.P |
|
1999 |
|
5S1 |
p. 19S-21S nvt p. |
artikel |
147 |
Pediatric bone and mineral working group
|
|
|
1998 |
|
5S1 |
p. S38- 1 p. |
artikel |
148 |
Perspective on the Impact of Weightlessness on Calcium and Bone Metabolism
|
Holick, M.F |
|
1998 |
|
5S1 |
p. 105S-111S nvt p. |
artikel |
149 |
Plenary lectures
|
|
|
1998 |
|
5S1 |
p. S146- 1 p. |
artikel |
150 |
Plenary lectures
|
|
|
2001 |
|
5S1 |
p. S66-S69 4 p. |
artikel |
151 |
Possible mechanisms of the analgesic action of calcitonin
|
Azria, M |
|
2002 |
|
5S1 |
p. 80-83 4 p. |
artikel |
152 |
Poster presentations
|
|
|
2001 |
|
5S1 |
p. S101-S248 148 p. |
artikel |
153 |
Poster session III
|
|
|
1998 |
|
5S1 |
p. S83-S109 27 p. |
artikel |
154 |
Poster session IV
|
|
|
1998 |
|
5S1 |
p. S115- 1 p. |
artikel |
155 |
Post transplantation bone disease working group
|
|
|
1998 |
|
5S1 |
p. S2- 1 p. |
artikel |
156 |
Potential Role of rhIGF-I/IGFBP-3 in Maintaining Skeletal Mass in Space
|
Tanaka, H |
|
1998 |
|
5S1 |
p. 145S-147S nvt p. |
artikel |
157 |
Prediction and assessment of the response of Paget’s disease to bisphosphonate treatment
|
Hosking, D.J |
|
1999 |
|
5S1 |
p. 69S-71S nvt p. |
artikel |
158 |
Preface - Innovation in postmenopausal osteoporosis: A therapeutic breakthrough
|
|
|
2007 |
|
5S1 |
p. viii- 1 p. |
artikel |
159 |
Program: Friday, June 8, 2001
|
|
|
2001 |
|
5S1 |
p. S40-S44 5 p. |
artikel |
160 |
Program: Saturday, June 9, 2001
|
|
|
2001 |
|
5S1 |
p. S45-S63 19 p. |
artikel |
161 |
Program: Sunday, June 10, 2001
|
|
|
2001 |
|
5S1 |
p. S64-S65 2 p. |
artikel |
162 |
Program: Thursday, June 7, 2001
|
|
|
2001 |
|
5S1 |
p. S23-S39 17 p. |
artikel |
163 |
Program: Tuesday, June 5, 2001
|
|
|
2001 |
|
5S1 |
p. S1-S4 4 p. |
artikel |
164 |
Program: Wednesday, June 6, 2001
|
|
|
2001 |
|
5S1 |
p. S5-S22 18 p. |
artikel |
165 |
PTH/PTHrP and calcitonin — ligand interactions working group
|
|
|
1998 |
|
5S1 |
p. S75- 1 p. |
artikel |
166 |
Quantitative bone scintigraphy in the management of Paget’s disease of bone
|
Dońath, J |
|
1999 |
|
5S1 |
p. 52S-53S nvt p. |
artikel |
167 |
Renal osteodystrophy working group
|
|
|
1998 |
|
5S1 |
p. S112- 1 p. |
artikel |
168 |
Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer
|
Ringe, Johann D. |
|
2007 |
|
5S1 |
p. S41- 1 p. |
artikel |
169 |
Satellite symposia
|
|
|
2001 |
|
5S1 |
p. S249-S254 6 p. |
artikel |
170 |
Severe orthopaedic complications of Paget’s disease
|
Kaplan, F.S |
|
1999 |
|
5S1 |
p. 43S-46S nvt p. |
artikel |
171 |
Short communications
|
|
|
2001 |
|
5S1 |
p. S90-S100 11 p. |
artikel |
172 |
Short-term therapy with oral olpadronate in very active Paget’s disease
|
Mautalen, C |
|
1999 |
|
5S1 |
p. 93S- 1 p. |
artikel |
173 |
Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study
|
Buckler, H |
|
1999 |
|
5S1 |
p. 81S-85S nvt p. |
artikel |
174 |
Skeletal safety of tiludronate
|
Neer, R.M. |
|
1995 |
|
5S1 |
p. S501-S503 3 p. |
artikel |
175 |
Special session for allied health professionals
|
|
|
1998 |
|
5S1 |
p. S6-S34 29 p. |
artikel |
176 |
Sponsored symposium
|
|
|
1998 |
|
5S1 |
p. S2- 1 p. |
artikel |
177 |
Sponsored symposium
|
|
|
1998 |
|
5S1 |
p. S75- 1 p. |
artikel |
178 |
Sponsored symposium
|
|
|
1998 |
|
5S1 |
p. S39- 1 p. |
artikel |
179 |
Sponsored symposium on impact of new bone assessment technologies on the management of the osteoporotic patient
|
|
|
1998 |
|
5S1 |
p. S111- 1 p. |
artikel |
180 |
Sponsoring organizations
|
|
|
2001 |
|
5S1 |
p. ix-x nvt p. |
artikel |
181 |
Strontium ranelate: New insights into its dual mode of action
|
Marie, Pierre J. |
|
2007 |
|
5S1 |
p. S5-S8 4 p. |
artikel |
182 |
Subject index
|
|
|
2001 |
|
5S1 |
p. S255-S274 20 p. |
artikel |
183 |
Surgical treatment of complications of Paget’s disease
|
Kenwright, J |
|
1999 |
|
5S1 |
p. 51S- 1 p. |
artikel |
184 |
Table of contents
|
|
|
2001 |
|
5S1 |
p. iii-iv nvt p. |
artikel |
185 |
The Gerald Aurbach memorial lecture
|
|
|
1998 |
|
5S1 |
p. S5- 1 p. |
artikel |
186 |
The inter-relationship between bone mineral density, turnover and structural properties in determining bisphosphonate efficacy
|
Epstein, Sol |
|
2007 |
|
5S1 |
p. S45- 1 p. |
artikel |
187 |
The methodology of clinical trials of oral tiludronate in Paget's disease of bone
|
Roux, C. |
|
1995 |
|
5S1 |
p. S497-S499 3 p. |
artikel |
188 |
The osteocyte working group
|
|
|
1998 |
|
5S1 |
p. S76- 1 p. |
artikel |
189 |
Therapeutic strategy in Paget's disease of bone
|
Meunier, P.J. |
|
1995 |
|
5S1 |
p. S489-S491 3 p. |
artikel |
190 |
The reality of therapeutic adherence
|
Rizzoli, René |
|
2007 |
|
5S1 |
p. S36-S37 2 p. |
artikel |
191 |
Thermal imaging in Paget’s disease of bone
|
Ring, E.F.J |
|
1999 |
|
5S1 |
p. 53S- 1 p. |
artikel |
192 |
The use of risedronate in Paget’s disease
|
Miller, P.D |
|
1999 |
|
5S1 |
p. 91S-92S nvt p. |
artikel |
193 |
The worldwide problem of osteoporosis: Insights afforded by epidemiology
|
Riggs, B.L. |
|
1995 |
|
5S1 |
p. S505-S511 7 p. |
artikel |
194 |
Tiludronate: Bone pharmacology and safety
|
Bonjour, J-P. |
|
1995 |
|
5S1 |
p. S473-S477 5 p. |
artikel |
195 |
Tiludronate: Development as an osteoporosis therapy
|
Chesnut III, C.H. |
|
1995 |
|
5S1 |
p. S517-S519 3 p. |
artikel |
196 |
Tiludronate for bone diseases Proceedings of a satellite symposium held at the XIIth international conference on calcium regulating hormones (ICCRH), Melbourne, Australia, 14 February, 1995
|
Chesnut III, C.H. |
|
1995 |
|
5S1 |
p. S471- 1 p. |
artikel |
197 |
Tiludronate therapy for Paget's disease of bone
|
McClung, M.R. |
|
1995 |
|
5S1 |
p. S493-S496 4 p. |
artikel |
198 |
Timetable
|
|
|
2001 |
|
5S1 |
p. xiv- 1 p. |
artikel |
199 |
Tolerability of less frequent dosing with ibandronate
|
Cannata-Andia, Jorge |
|
2007 |
|
5S1 |
p. S34-S35 2 p. |
artikel |
200 |
Treatment of Paget’s disease of bone with alendronate
|
Lombardi, A |
|
1999 |
|
5S1 |
p. 59S-61S nvt p. |
artikel |
201 |
Treatment of Paget’s disease with tiludronate
|
Fraser, W.D |
|
1999 |
|
5S1 |
p. 68S- 1 p. |
artikel |
202 |
Urinary crosslinked N-telopeptide of type I collagen and crosslaps as markers of bone resorption in patients with Paget’s disease of bone
|
Iqbal, S.J. |
|
1999 |
|
5S1 |
p. 52S- 1 p. |
artikel |
203 |
Use of Calcium Tracers and Biomarkers to Determine Calcium Kinetics and Bone Turnover
|
Weaver, C.M |
|
1998 |
|
5S1 |
p. 103S-104S nvt p. |
artikel |
204 |
Vitamin D research frontiers — 1998 evening update working group
|
|
|
1998 |
|
5S1 |
p. S3- 1 p. |
artikel |
205 |
Welcome reception and plenary posters
|
|
|
1998 |
|
5S1 |
p. S37- 1 p. |
artikel |
206 |
Working group on aging and the human skeleton
|
|
|
1998 |
|
5S1 |
p. S39- 1 p. |
artikel |
207 |
Working group on biochemical markers of bone turnover
|
|
|
1998 |
|
5S1 |
p. S3- 1 p. |
artikel |
208 |
Working group on quality of life and rehabilitation in patients with osteoporosis
|
|
|
1998 |
|
5S1 |
p. S38- 1 p. |
artikel |
209 |
Working group on quantitative ultrasound techniques in osteoporosis
|
|
|
1998 |
|
5S1 |
p. S37- 1 p. |
artikel |